Filing Details
- Accession Number:
- 0001225208-11-012410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-28 13:44:15
- Reporting Period:
- 2011-04-28
- Filing Date:
- 2011-04-28
- Accepted Time:
- 2011-04-28 13:44:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
901219 | Human Genome Sciences Inc | HGSI | Biological Products, (No Disgnostic Substances) (2836) | 223178468 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1191234 | D. Susan Bateson | 14200 Shady Grove Road Rockville MD 20850 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-04-28 | 3,000 | $30.00 | 62,270 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person and Merrill Lynch effective March 21, 2011.